Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sichuan Kelun-Biotech Biopharmaceutical synthesizes USP7 inhibitors

Nov. 3, 2020

Peloton Therapeutics identifies RBM39 degradation inducers

Nov. 3, 2020

Rottapharm Biotech discloses new DDR2 inhibitors

Nov. 3, 2020

PRIMEGENE BEIJING discovers TYK2 inhibitors

Nov. 2, 2020

New RET inhibitors identified at Zhejiang Hisun Pharmaceutical

Nov. 2, 2020

Preclinical data support ongoing clinical development of ASTX-029

Nov. 2, 2020

BioLineRx stops enrolling patients in GENESIS study based on positive interim data

Nov. 2, 2020

First results from IPAX-1 clinical trial for GBM

Oct. 30, 2020

Accutar Biotechnology synthesizes new PROTACs for cancer

Oct. 30, 2020

Qilu Regor Therapeutics identifies tyrosine kinase inhibitors

Oct. 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...